PINI, Luigi Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.204
EU - Europa 8.992
AS - Asia 5.985
SA - Sud America 895
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 11
Totale 32.190
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.050
GB - Regno Unito 3.381
IT - Italia 2.530
CN - Cina 2.284
SG - Singapore 1.746
HK - Hong Kong 817
BR - Brasile 714
SE - Svezia 705
DE - Germania 493
UA - Ucraina 475
VN - Vietnam 316
RU - Federazione Russa 284
FI - Finlandia 265
TR - Turchia 260
FR - Francia 217
KR - Corea 216
NL - Olanda 189
BG - Bulgaria 168
CA - Canada 103
ID - Indonesia 102
AR - Argentina 74
IE - Irlanda 72
IN - India 52
BE - Belgio 35
EC - Ecuador 34
BD - Bangladesh 32
ES - Italia 32
MX - Messico 32
ZA - Sudafrica 31
CH - Svizzera 27
JP - Giappone 25
AT - Austria 24
IR - Iran 24
CL - Cile 20
PL - Polonia 19
IQ - Iraq 17
BY - Bielorussia 15
CO - Colombia 15
EU - Europa 13
MA - Marocco 13
PK - Pakistan 13
LT - Lituania 12
VE - Venezuela 11
NO - Norvegia 9
PE - Perù 9
PY - Paraguay 9
TN - Tunisia 9
IL - Israele 8
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
DZ - Algeria 6
KZ - Kazakistan 6
NP - Nepal 6
RO - Romania 6
SA - Arabia Saudita 6
SN - Senegal 6
UY - Uruguay 6
YE - Yemen 6
CZ - Repubblica Ceca 5
MY - Malesia 5
PH - Filippine 5
PT - Portogallo 5
AL - Albania 4
ET - Etiopia 4
KE - Kenya 4
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
JO - Giordania 3
RS - Serbia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BH - Bahrain 2
BW - Botswana 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AD - Andorra 1
BB - Barbados 1
Totale 32.173
Salva come PNG Salva come JPEG
Città #
Southend 2.672
Fairfield 1.718
Santa Clara 1.658
Woodbridge 1.392
Ashburn 1.317
Jacksonville 1.005
Singapore 975
Houston 956
Hefei 922
Hong Kong 809
Chandler 798
Dearborn 640
Wilmington 633
Seattle 591
Cambridge 573
Ann Arbor 561
Beijing 391
London 387
Nyköping 361
Los Angeles 240
Chicago 229
Seoul 202
Milan 198
Princeton 197
Modena 193
San Diego 175
Sofia 165
Eugene 162
Izmir 142
Buffalo 129
Rome 125
Helsinki 109
New York 109
Ho Chi Minh City 108
Moscow 105
The Dalles 100
Dallas 96
Council Bluffs 82
Salt Lake City 81
Jakarta 76
Redwood City 69
Dublin 67
Shanghai 67
Des Moines 64
Hanoi 63
São Paulo 56
Turin 54
Bologna 52
Naples 52
Genoa 36
Nanjing 36
Columbus 35
Elk Grove Village 35
Brussels 33
Dong Ket 33
Ottawa 32
Rio de Janeiro 31
Tampa 31
Verona 31
Bianco 29
Norwalk 29
Bremen 28
Palermo 28
Phoenix 28
Lancaster 27
Brooklyn 26
Falls Church 26
Boardman 25
Guangzhou 25
Munich 25
Brescia 24
Florence 24
Toronto 23
Parma 22
Tulare 21
Fremont 20
Jinan 20
Orem 20
Tokyo 20
Atlanta 19
Catania 19
Paris 18
Philadelphia 18
Sterling 18
Perugia 17
Boston 16
Denver 16
Redondo Beach 16
Warsaw 16
Bari 15
Johannesburg 15
Miami 15
Reggio Emilia 15
San Francisco 15
Venice 15
Chiswick 14
Como 14
Dongguan 14
Guayaquil 14
Indiana 14
Totale 23.082
Salva come PNG Salva come JPEG
Nome #
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 1.828
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. 741
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 370
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 369
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 321
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 308
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 307
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages 295
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache 282
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 280
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 280
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 279
Endocannabinoids in chronic migraine: CSF findings suggest a system failure 277
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 275
Basal cutaneous pain threshold in headache patients 272
A preliminary study on the relationship between central auditory processing and childhood primary headaches in the intercritical phase 268
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 262
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache 262
NF-kappa B activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks 261
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 259
A case-control study of visually evoked postural responses in childhood with primary headaches 255
O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache 250
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 244
Anti-epileptic drugs in the preventive treatment of migraine headache : a brief review. 239
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis 239
A case of a GH-producing pituitary adenoma associated with a unilateral headache with autonomic signs 237
Headaches associated with chronic use of analgesics: A therapeutic approach 232
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 231
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 231
Diamo parole al dolore. La percezione del disagio e della difficoltà nella vita quotidiana delle bambine e dei bambini 230
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 229
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 228
Long-term follow-up of patients treated for chronic headache with analgesic overuse 225
Phenytoin-Treatment Of Rdeb Vegetans 225
A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse 225
Effect of rofecoxib on nociception and the serotonin system in the rat brain 224
Italian guidelines for primary headaches: 2012 revised version. 224
An unusual case report on the possible role of Warfarin in migraine prophylaxis 223
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 223
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 222
Disposition of naproxen after oral administration during and between migraine attacks. 221
Analgesic abuse in chronic headache sufferers 221
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 219
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 219
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 217
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 212
Risk-benefit and cost-benefit ratio in headache treatment 211
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 210
Plasma glutathione level in chronic headache drug abuser patients 205
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 205
INTERNATIONAL-HEADACHE-SOCIETY CLASSIFICATION - INTEROBSERVER RELIABILITY IN THE DIAGNOSIS OF PRIMARY HEADACHES 204
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium 204
Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage 203
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 203
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 201
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 200
Relevance of analgesic abuse in the maintenance of chronic headaches 199
An emerging problem in clinical practice: how to treat chronic headache patients. 199
Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study. 199
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 198
Different characteristics of triptans 197
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 196
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 195
Homocysteine levels and cardiovascular disease in migraine with aura 195
Triptans: the experience of a clinical pharmacologist in clinical practice. 193
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 192
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. A comment. 191
Chronic daily headache: how to manage it? 191
Lack of association between five serotonin metabolism-relatedgenes and medication overuse headache. 191
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study 190
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 188
DOES CHRONIC USE OF SUMATRIPTAN INDUCE DEPENDENCE 188
HIGH EFFICACY AND LOW-FREQUENCY OF HEADACHE RECURRENCE AFTER ORAL SUMATRIPTAN 187
Tacrolimus pharmacokinetics in kidney transplant recipients. 186
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 186
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 186
Nimodipine in otolaryngology: from past evidence to clinical perspectives 186
Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study. 184
Analysis on the use of migraine preventative drugs in current clinical practice 183
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study 183
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels 183
Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial 182
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 182
Evaluation of a possible relationship between medication-overuse headache and potential renal dysfunctions by a proteomic study on urine samples 181
Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: Comparison of methods 178
Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders 177
Active reporting scheme: an example to evaluate specific adverse drug reactions. 177
Topo-kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report 177
Pharmacokinetics of tia profenic acid in headache attacks - a preliminary report 176
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 176
High prevalence of patent foramen ovale in migraine with aura 176
Circadian variations of proopiocortin-related peptides in children with migraine. 175
PHARMACOKINETICS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS 175
Urinary neopterin in malignant lymphoma 174
Ambiti e limiti delle prescrizioni farmaceutiche nell'esercizio dell'odontoiatria e protesi dentaria 173
Chronic treatment with naltrexone and hepatic functions in heroin addicts 173
Psycological profiles in tobacco and drug abusers 167
INFLUENCE OF FLUNARIZINE ON THE ALTERED ELECTRONYSTAGMOGRAPHIC (ENG) RECORDINGS IN MIGRAINE 167
Treatment of chronic overmedicated headache patients 166
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 166
Totale 23.871
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.910 0 0 0 0 0 224 306 444 110 468 190 168
2021/20222.935 92 450 319 326 66 75 194 139 279 198 443 354
2022/20232.399 308 231 141 208 268 363 49 213 300 51 120 147
2023/20242.231 116 143 158 171 370 166 200 268 93 83 223 240
2024/20256.336 282 117 155 473 1.230 883 341 311 840 467 595 642
2025/20265.334 716 540 1.207 1.289 1.331 251 0 0 0 0 0 0
Totale 32.296